Mind Medicine (MindMed) Inc.

Jun 02, 2020

MindMed's Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSD For Adult ADHD

Apr 22, 2020

Psychedelic Pharmaceutical Company MindMed Develops LSD Neutralizer Technology To Shorten and Stop LSD Trips

Apr 20, 2020

MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations

Apr 17, 2020

REPEAT: MindMed Initiates Dosing in Human Safety Study of Novel Treatment for Opioid Addiction, 18-MC

Apr 16, 2020

MindMed Initiates Dosing in Human Safety Study of Novel Treatment for Opioid Addiction, 18-MC

Apr 01, 2020

MindMed Acquires Exclusive License to Eight Clinical Trials of LSD, Partners with World-Leading Psychedelic Research Laboratory at University Hospital Basel

Mar 30, 2020

MindMed Reports Year-end Results and Corporate Update